I'd like to apply for this job buy antabuse baikal-pharmacy THE NUMBERS: The company reported net income of $1.23 billion, or $1.88 per share, compared with a loss of $1.84 billion, or $2.74 per share, in the prior-year quarter. Revenue grew to $3 billion from $2.6 billion a year earlier.
